Growth Metrics

Skinvisible (SKVI) EPS (Basic) (2016 - 2025)

Skinvisible's EPS (Basic) history spans 16 years, with the latest figure at -$0.05 for Q3 2025.

  • For Q3 2025, EPS (Basic) rose 16.67% year-over-year to -$0.05; the TTM value through Sep 2025 reached -$0.07, up 72.0%, while the annual FY2024 figure was -$0.11, 78.85% up from the prior year.
  • EPS (Basic) for Q3 2025 was -$0.05 at Skinvisible, roughly flat from -$0.05 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.08 in Q4 2024 and bottomed at -$0.33 in Q1 2023.
  • The 5-year median for EPS (Basic) is -$0.06 (2021), against an average of -$0.07.
  • The largest annual shift saw EPS (Basic) tumbled 560.0% in 2023 before it skyrocketed 233.33% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.04 in 2021, then crashed by 125.0% to -$0.09 in 2022, then surged by 33.33% to -$0.06 in 2023, then surged by 233.33% to $0.08 in 2024, then tumbled by 162.5% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's EPS (Basic) are -$0.05 (Q3 2025), -$0.05 (Q2 2025), and -$0.05 (Q1 2025).